PenderFund Capital Management’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

PenderFund Capital Management’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-53,598	Closed	-$4K	–	135
2023 Q3	$4K	Hold	53,598	–	–	﹤0.01%	105
2023 Q2	$15K	Hold	53,598	–	–	﹤0.01%	103
2023 Q1	$12K	Hold	53,598	–	–	﹤0.01%	119
2022 Q4	$16K	Hold	53,598	–	–	﹤0.01%	132
2022 Q3	$195K	Sell	53,598 -3,600	-6%	-$5.3K	0.06%	109
2022 Q2	$50K	Hold	57,198	–	–	0.01%	150
2022 Q1	$113K	Hold	57,198	–	–	0.03%	96
2021 Q4	$173K	Hold	57,198	–	–	0.04%	65
2021 Q3	$299K	Sell	57,198 -3,300	-5%	-$12.4K	0.08%	56
2021 Q2	$277K	Buy	+60,498	New	+$273K	0.06%	61

Other funds holding CANO.WS

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

PenderFund Capital Management's CANO.WS Position: Q4 2023 in Review

PenderFund Capital Management sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 53,598 shares — an estimated $4K sold.

PenderFund Capital Management first reported a position in CANO.WS in Q2 2021 and held it in 10 quarters. The position peaked at $299K in Q3 2021. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.

PenderFund Capital Management reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
PenderFund Capital Management sold 53,598 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $4K.
PenderFund Capital Management first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 10 quarters.
PenderFund Capital Management's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $299K in Q3 2021.
2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.

Based on PenderFund Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.